Market Research Report
Digital Pathology: Technologies and Global Markets
|Published by||BCC Research||Product code||296550|
|Published||Content info||185 Pages
Delivery time: 1-2 business days
|Digital Pathology: Technologies and Global Markets|
|Published: September 25, 2019||Content info: 185 Pages||
The global digital pathology market should reach $10.2 billion by 2023 from $4.8 billion in 2018 at a compound annual growth rate (CAGR) of 16.5% for the period of 2018 to 2023.
North American region of the global digital pathology market is expected to grow from $1.9 billion in 2018 to $3.9 billion in 2023 at a CAGR of 16.1% for the period of 2018 to 2023.
European region of the global digital pathology market is expected to grow from $1.5 billion in 2018 to $3.1 billion in 2023 at a CAGR of 15.9% for the period of 2018 to 2023.
This report includes forecasted trends and sales in the digital pathology and telepathology markets through 2023. Key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence, and regional trends are discussed. There is a detailed discussion on market dynamics and the level of impact, key geographies and respective trends, and competitive scenarios that will form the base data for qualitative analysis and market estimates.
The digital pathology and telepathology market has been analyzed for the four main geographic regions: North America, Europe, Asia and the rest of the world (ROW).
The report will provide details with respect to the conventional process of pathology laboratories, but it will specifically exclude the scope of market analysis for conventional path-lab devices (e.g., conventional microscopes, slides). The connectivity and network issues discussed in the report will be specific to data and information generated from pathology labs and that regarding specific diagnosis; but it will exclude general hospital-based m-health issues. Telepathology covered in the report is limited to diagnostic, research and development (R&D), and education and training applications. It excludes the scope of telemedicine at a larger level.